Allianz Asset Management »

Denali Therapeutics shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $331k 15k 21.46
2023-09-30 $303k 15k 20.63
2023-06-30 $434k 15k 29.51
2023-03-31 $260k 11k 23.04
2022-12-31 $314k 11k 27.81
2022-09-30 $347k 11k 30.71
2022-06-30 $436k 15k 29.42
2022-03-31 $574k 18k 32.19
2021-12-31 $1.6M 36k 44.62
2021-09-30 $945k 19k 50.44
2021-06-30 $1.8M 24k 78.47
2021-03-31 $1.3M 24k 57.11
2020-12-31 $2.7M 32k 83.74
2019-12-31 $578k 33k 17.42
2019-09-30 $938k 61k 15.33
2019-06-30 $1.3M 61k 20.76
2019-03-31 $2.3M 100k 23.22
2018-12-31 $1.9M 91k 20.66
2018-09-30 $4.9M 223k 21.74
2018-06-30 $3.6M 237k 15.25
2018-03-31 $4.7M 236k 19.69
2017-12-31 $3.1M 200k 15.64